ライフサイエンスコーパス: immune status

1 w CD4+ cell count (a clinical measurement of immune status).

2 ve patients and mortality, given a patient's immune status.

3 is differ depending on the host's underlying immune status.

4 ers of mineral metabolism, inflammation, and immune status.

5 of the exposure to the organism and the host immune status.

6 fore in their potential contribution to host immune status.

7 tly before and after surgery as a measure of immune status.

8 used approach for profiling the population's immune status.

9 g levels alone may not reflect the patient's immune status.

10 ses in young mice regardless of the maternal immune status.

11 alopathy (PML) in individuals with depressed immune status.

12 inal disease caused by VZV may relate to the immune status.

13 one site occurred independently of adaptive immune status.

14 mifications for people of different ages and immune status.

15 depending on the infecting organism and host immune status.

16 antibody-based interventions and monitoring immune status.

17 pleen and was associated with improvement in immune status.

18 icient mice, but did little to improve their immune status.

19 mably related to inflammation rather than to immune status.

20 ar forms is a function of alteration in host immune status.

21 lements play a role in a mother's postpartum immune status.

22 on for clinical assessment of posttransplant immune status.

23 ecies, age, sex, reproductive condition, and immune status.

24 nd have a positive effect on food intake and immune status.

25 tted at a high rate (18%-27%), regardless of immune status.

26 trains from all four serotypes regardless of immune status.

27 may not be entirely dependent on the host's immune status.

28 zh2 in atherosclerosis and T cell-associated immune status.

29 sess acute and persisting (7 day) changes in immune status.

30 of the combination therapy depends on tumor immune status.

31 et of MIA offspring (~ 40%, 13/32) with high immune status.

32 d on duration of infection and the patient's immune status.

33 signaling, regardless of tumor type or host immune status.

34 d dengue severity, regardless of serotype or immune status.

35 t the potentiation varies depending on tumor immune status.

36 L-12, should be predominantly based on tumor immune status.

37 postoperative period based on assessments of immune status.

38 l risk ratio is stable to selection based on immune status.

39 tory responses, which involve a hyper-active immune status.

40 et of MIA offspring (~ 40%, 13/32) with high immune status.

41 tment, risk factors, clinical situation, and immune status.

42 ar age inadequately reflects an individual's immune status.

43 can be used to predict patient prognosis and immune status.

44 s in known socio-structural determinants and immune status.

45 ation in the URT were compared based on host immune status.

46 of HPV infection also depends on the host's immune status.

47 ion, possibly contributing to differences in immune status.

48 luding screening history, exposure, age, and immune status.

49 ILA and establishes a constitutive SAR-like immune status.

50 protection and differential risk by age and immune status.

51 SA, and ILA in concert to balance the plant immune status.

52 a-infected humans regardless of age, sex, or immune status.

53 ity has no appreciable consequences on their immune status.

54 valuate its association with patient age and immune status.

55 izophrenia cases (~ 45%, 13/28) showing high immune status.

56 tion with bacterial or viral mimics to alter immune status.

57 n death, with symptoms being related to host immune status.

58 us (DENV) serotype and prevaccination dengue immune status.

59 xic effects, and monitoring of the patients' immune status.

60 y ill patients in the ICU according to their immune status.

61 ries depending on DENV serotype and previous immune status.

62 nt and sequential assessments of recipient's immune status.

63 community in which they reside and the host immune status.

64 HPV-microbiota relationship, controlling for immune status.

65 n leading to profound changes in the tumor's immune status.

66 factors, including breed, age, and adaptive immune status.

67 al promoters that have evolved to sense host immune status.

68 ted whether ATG use induces a proatherogenic immune status.

69 aspergillosis (IA), depending on the host's immune status.

70 e mechanism of immunosuppression or shift in immune status.

71 y region, full health insurance coverage, or immune status.

72 l autochthonous cancer models with different immune status: (1) Early Tag-specific CTL competence and

73 modeled partially effective postvaccination immune status 4 ways: use of PBMCs from highly exposed,

74 Depending on virus strain and host immune status, acute infections by IAV may reach sites o

75 plotypes and their genotypic combinations to immune status after measles-mumps-rubella (MMR) vaccinat

76 ngenital CMV infection according to maternal immune status, age, race, parity, and socioeconomic stat

77 with SUDs might be curtailed by compromised immune status and a greater likelihood of exposures, add

78 rding the use of serological tests to assure immune status and a public health ethics perspective to

79 clude that the WD is reprogramming the basal immune status and acute response to LPS-driven sepsis an

80 lucocorticoid drug therapies that compromise immune status and affect survival outcomes in neuro-onco

81 al factors such as age at infection, gender, immune status and alcohol consumption has long been reco

82 ystin-LR exposure and its connection to host immune status and antimicrobial resistance that can be c

83 acterial pathogens may be influenced by host immune status and by concurrent infections.

84 al exposure to improve mouse models of human immune status and disease.

85 ence both cellular and humoral indicators of immune status and function.

86 In the present study, we characterized the immune status and functional properties of immune cells

87 or intrinsic pathways associated with their immune status and immunoediting history.

88 biota but also the donors' intestinal innate immune status and improved intestinal integrity.

89 e eyes evoked no change in recipient humoral immune status and induced mild guinea pig-specific DTH o

90 and prognostic biomarker sensing the host's immune status and inflammatory stage.

91 ly nonspecific suppression of the recipients immune status and later recovery of third-party immunore

92 might also depend on the patient's specific immune status and not only on the material used.

93 also interacts with it and thus affects host immune status and physiology.

94 nal secretions might modulate the intestinal immune status and possibly delay rejection.

95 ly reactivate, and - depending on the host's immune status and site of reactivation - encephalitis or

96 ility to infection is known to vary with the immune status and strain of the host, but little is know

97 ith cancer may be affected by the underlying immune status and the anticancer therapy received.

98 xt dependent, being influenced by the host's immune status and the microbial milieu.

99 There was no association between the immune status and the occurrence of ICU-acquired infecti

100 ty of infection (MOI) can be an indicator of immune status and transmission intensity.

101 evels in plasma are valuable measurements of immune status and treatment effects in human immunodefic

102 d, and its replication is closely related to immune status and viral coinfection.

103 sequences) to comparatively assess baseline immune statuses and responses to influenza vaccination i

104 A and LA were equivalent for determining VZV immune status, and both methods required modified criter

105 ntroversial and varies according to species, immune status, and cancer type.

106 agments to image the tumor microenvironment, immune status, and changes over the course of therapy.

107 mptomatic infections, check the individual's immune status, and confirm vaccine efficacy and durabili

108 The patient's age, immune status, and DLBCL treatments are factors that con

109 xposure factors (environmental and dietary), immune status, and dysbiosis.

110 and outcome to differ by age, serotype, host immune status, and illness day at study enrollment.

111 ed with low-level HIV-1 RNA in blood, better immune status, and lower ART drug distribution into CSF.

112 the risk of cardiovascular disease, enhance immune status, and otherwise modulate important degenera

113 diseases, the assessment of an individual's immune status, and possible protection against infection

114 confirm incident cases of HZ, the patient's immune status, and prescribing of antivirals for HZ.

115 or depressive disorder, AIDS-related stigma, immune status, and sociodemographic variables with the a

116 Their physiology, immune status, and susceptibility to disease were assess

117 of diverticulitis, the patient's health and immune status, and the patient's preferences and values,

118 nts are more common in patients with a naive immune status, and/or adverse inflammatory host response

119 rthermore, correlates between ADCC and HIV-1 immune status are not clearly defined.

120 Importantly, sex differences in immune status are stronger during the breeding period th

121 e levels in the gut join the oocyst dose and immune status as important factors that determine the ou

122 etine treatment is associated with change in immune status as measured by CD4 cell count.

123 transcriptional states defined the baseline immune status associated with high antibody responders t

124 tory illness (LRI) risk in early life or RSV immune status at birth is unclear.

125 yellow fever vaccination depends on age and immune status at primary vaccination.

126 h active severe sepsis to characterize their immune status at the time of death (2009-2011).

127 We recommend establishing the patient's VZV immune status before initiating fingolimod therapy and i

128 Neither vaccinia-immune status before vaccination nor ALVAC dose affected

129 ne aging (IMM-AGE) that describes a person's immune status better than chronological age.

130 IV treatment and status, liver function, and immune status, both the prevalence and incidence of HIV-

131 kocytes are not only altered in their innate immune status but also have distinct T-cell phenotypes t

132 Few studies reported immune status, but where reported CD4 count at diagnosis

133 ata demonstrate that the host's inflammatory immune status can limit the efficacy of microbiota-based

134 ospective studies, taking into consideration immune status, CD4 cell counts, the presence of systemic

135 aluation included gross findings, changes in immune status changes, production of donor-specific anti

136 Regardless of immune status, children have a crucial role in Omicron h

137 Data on the immune status, clinical characteristics, and therapeutic

138 ral estrogen-dependent changes in the rhesus immune status coincided with susceptibility to infection

139 Critically ill patients' immune status could be captured through the combined mon

140 e in antibody positivity relative to patient immune status, degree of disease dissemination, or sympt

141 catheter duration, study design, and patient immune status demonstrated no significant differences.

142 esent in an organism therefore report on its immune status, describe its innate ability to deal with

143 increased, indicating that the XLRS baseline immune status differs from that of controls.

144 mmune responses against EBOV GP and that Ad5 immune status does not affect the generation of GP-speci

145 was identified as a potential biomarker for immune status during an active infection.

146 hich correlate with disease severity or host immune status exist.

147 and being on antivirals but not with gender, immune status, extent of rash, the age of the rash at th

148 egistries, including precise anatomic sites, immune status, family and personal cancer history, and g

149 uman serum contains abundant evidence of the immune status following infection.

150 With improvement in the immune status following treatment with antiretrovirals,

151 hat an LA-2 titer is a reliable indicator of immune status for estimating immune protection following

152 protection, and determination of individual immune status for many viral diseases.

153 wn whether hemoglobin normalization improves immune status further.

154 bacteria are complex and may be dependent on immune status/genetics of the host.

155 o predict the association between peripheral immune status, glucose intolerance and behavioral outcom

156 ns were consistent across age, serotype, and immune status groups, and in the various sensitivity and

157 patients but did not differ between various immune status groups.

158 HUU-p = 0.04; HEU vs. HUU-p = 0.11) however, immune status had stronger impacts on bacterial profiles

159 hosts, but laboratory confirmation of prior immune status has rarely been possible.

160 's disease varies with host strain, age, and immune status However, little is known about the role of

161 ociated with viral phenotypic differences or immune status, however, was not well understood.

162 Enteral formulations designed to improve immune status (immunonutrition) may prevent postoperativ

163 The underlying immune status impacts on the course of septic shock and

164 ted data with total calcineurin activity and immune status in a cohort of pretransplantation controls

165 To evaluate pathology and the role of immune status in a murine model system of human granuloc

166 mice after exposure to soil and by examining immune status in both a steady-state situation and durin

167 Hence, the ability to screen for EEHV immune status in elephant calves should have a major imp

168 tive IL-1 and IL-6 may contribute to altered immune status in HNSCC patients.

169 Gene expression and immune status in human tissues are changed with aging.

170 However, the role of tumor immune status in influencing these relationships remains

171 Little is known about the immune status in liver and blood of patients with chroni

172 results suggest that RT alters IDO-mediated immune status in NSCLC patients and that changes in this

173 TTV load was related to the immune status in patients after organ transplantation.

174 per-cell basis, reflecting a less exhausted immune status in the LTB state.

175 changes were assessed along with changes in immune status including delayed-type hypersensitivity, a

176 Collectively, our data show that peripheral immune status is a persistent, sex-dependent predictor o

177 ese observations indicate that (1) a similar immune status is achieved in long-surviving allografts a

178 Preexisting immune status is associated with subphenotype assignment

179 was used for antirejection therapy, (2) this immune status is characterized by continuous, long-term

180 n quickly and reliably confirm infection and immune status is extremely urgently and critically neede

181 Using REAnimation Low Immune Status Marker immunomonitoring panel, we detected

182 unteers were included in the REAnimation Low Immune Status Marker study.

183 rary to the belief that only the recipient's immune status matters, the data indicate that pretranspl

184 o non-HIV organ transplant recipients, whose immune status may vary due to the effects of immunosuppr

185 nces in aging rate, as monitored by tests of immune status, might accelerate or decelerate a wide ran

186 nt cells in MDS, and the current omission of immune status monitoring may in part explain the insuffi

187 s to be investigated for both prognostic and immune status monitoring purposes.

188 Irrespective of immune status, no in vivo reactivation was detected; how

189 With respect to immune status, no significant differences in preoperativ

190 fied in four subgroups with respect to their immune status: nonimmunocompromised and immunocompromise

191 In this work, we describe the immune status of a spontaneous melanoma mouse model that

192 lycan expressions is important to detect the immune status of animals/humans against T. gondii.

193 The effects of anti-CD44 treatment on the immune status of arthritic animals were also determined.

194 atters, the data indicate that pretransplant immune status of both donor and recipient influence post

195 on of the neonatal gut by SFB depends on the immune status of both mothers and pups.

196 hypothesis of transplant tolerance--that the immune status of both the organ recipient and the organ

197 could serve as important determinants of the immune status of human diseases in general, and thereby

198 produced heterozygous fetuses resembling the immune status of human fetuses.

199 The immune status of immunized mice was determined at the en

200 Noninvasive whole-body imaging of the immune status of individual patients during immunotherap

201 subsets and may be useful for assessing the immune status of individuals infected with HIV-1.

202 us would facilitate the determination of the immune status of individuals who have Coronavirus diseas

203 critical to surveillance, assessment of the immune status of individuals, vaccine development, and b

204 esponse are nonselective with respect to the immune status of individuals.

205 ow dengue transmissibility may depend on the immune status of infected individuals and the identity o

206 is unclear how household composition and the immune status of inhabitants affect the individual risk

207 Is C. albicans capable of sensing the immune status of its host, a process we term immunosensi

208 However, the immune status of macrophages from peripheral compartment

209 ensals and the host impact the metabolic and immune status of metazoans.

210 h of infection, independent of the adaptive immune status of mice, and these cells disappear by day

211 ghlights the importance of understanding the immune status of non-HIV organ transplant recipients wit

212 However, the immune status of normal colorectal mucosa in LS is not w

213 emonstrate the importance of considering the immune status of nursing mothers in studies of immune de

214 Thus, we know little of the immune status of patients in the immediate postinjury ph

215 nvasive method for evaluation of system-wide immune status of patients with non-small cell lung cance

216 The inability to evaluate the immune status of patients with sepsis in a rapid and qua

217 A detailed study of the immune status of patients with STS revealed a striking T

218 , ocular findings including the type of HSK, immune status of patients, antiviral treatments, and HSV

219 d complications are related, in part, to the immune status of patients.

220 19 breakthrough infection, regardless of the immune status of patients.

221 Initially, the immune status of peripheral blood mononuclear cells was

222 Defining how the in vivo immune status of peripheral tissues is shaped by the ext

223 rd (HDEst) affected the OVA-specific AHR and immune status of previously Th2-sensitized mice.

224 The immune status of putatively tolerant animals was examine

225 d nonresponders seemed to correlate with the immune status of the animals before treatment and were n

226 t the timing of viral administration and the immune status of the animals will be an important consid

227 ld, however, not be explained by the altered immune status of the atopic skin.

228 ad been preimmunized against Ad to mimic the immune status of the general human population.

229 The observation that the dengue immune status of the host affects the quality of the cro

230 The effect of dexamethasone on the immune status of the host as well as on the host metabol

231 a DTH-positive state, the importance of the immune status of the host before treatment remains large

232 Beyond cancer-cell intrinsic factors, the immune status of the host has a prognostic impact on pat

233 s, indicating the critical importance of the immune status of the host in this infection, but the def

234 y individuals but can cause disease when the immune status of the host is altered.

235 link between the requirement for ICL and the immune status of the host was established by the restore

236 manifestations are largely dependent on the immune status of the host, and given the ubiquitous natu

237 bles, such as the extent of the disease, the immune status of the host, and the virulence and the dru

238 HCMV pathogenesis is intimately tied to the immune status of the host, thus characterization of the

239 the dependence of microbial virulence on the immune status of the host.

240 se syndromes that loosely correlate with the immune status of the host.

241 dding which depends partially on the age and immune status of the host.

242 consistent with an activity connected to the immune status of the host.

243 to HSP60 provide a biomarker to monitor the immune status of the individual.

244 The timing of exposure, inoculum size, immune status of the infant, and virulence of the causat

245 These data suggest that the immune status of the lung of an individual may profoundl

246 rum infections in life are influenced by the immune status of the mother.

247 quired or nosocomial, as well as the age and immune status of the patient, can help to narrow the dif

248 quired or nosocomial, as well as the age and immune status of the patient, can help us in narrowing t

249 the responses that relate to the preexisting immune status of the persons.

250 me of these interactions might depend on the immune status of the subject.

251 do this, we sought correlations between the immune status of the subjects and the development of S.

252 ine-driven beta-AR signaling to regulate the immune status of the tumor microenvironment and support

253 required to clarify the HIV-1 infection and immune status of the vaccinee, including repeat RT-PCR,

254 myeloma (SMM), but no available data on the immune status of this particular disease stage.

255 Immune status of tumor-draining lymph nodes (n = 161) of

256 ppressive microenvironment by polarizing the immune status of tumours.

257 findings emphasize the need to consider the immune status of vaccine recipients and to implement app

258 finding could be the result of the healthier immune status of women who become pregnant or could poss

259 be a valuable asset in determining the EEHV immune status of young elephants and responses to candid

260 ariant, age, comorbidities, vaccination, and immune status on N and sgN Ct values were evaluated usin

261 diation and highlight the impact of the host immune status on salivary gland radiation injury.

262 monstrating the substantial effect of animal immune status on susceptibility to experimentally induce

263 estigated the effects of diet, phylogeny and immune status on the gut microbial communities of animal

264 V) irrespective of antiretroviral treatment, immune status, or disease stage.

265 l drugs, history of opportunistic infection, immune status, or duration of aminotransferase elevation

266 fecal shedding and age, sex, race/ethnicity, immune status, or symptoms of gastrointestinal disease i

267 cting variant but not with age, comorbidity, immune status, or vaccination.

268 at higher doses, some indication of restored immune status over 28 days.

269 and jejunal mucosa were collected to assess immune status, oxidative stress, barrier markers, cell p

270 rapy, histamine-2 (H2) receptor blocker use, immune status, parenteral nutrition, and length of stay.

271 y affected by multiple factors, such as host immune status, polymicrobial infection, and strain diver

272 that NK cell IS quality can directly affect immune status, providing a potential target for diagnosi

273 that CD8(+) TILs can reflect an individual's immune status, rather than exclusively representing TAA-

274 Maternal prenatal immune status related to methylome profiles in neonates

275 Our findings identify clear serotype and immune-status related effects on the dynamics of dengue

276 ce criteria based on CSF parameters and host immune status saved time and cost and did not miss patie

277 For immune status, sensitivity and specificity were 0.91 and

278 Maternal prenatal immune status shapes asthma development in her child by

279 ddress concurrent antiretroviral therapy and immune status should be designed in a manner that is app

280 of NAC1 on tumor growth varies with the host immune status, showing diminished tumorigenicity in natu

281 June 1999 underwent a posttransplant humoral immune status survey as part of routine posttransplant f

282 site metric that better reflects a patient's immune status than their calendar age.

283 ay contribute to the alterations in acquired immune status that frequently accompany sepsis.

284 nderstanding of the complex interplay of the immune status, therapeutic regimen, and disease allows i

285 eening criteria based on CSF values and host immune status to guide testing.

286 , including demographics, clinical features, immune status, treatments, and mortality.

287 n including demographics, clinical features, immune status, treatments, and mortality.

288 However, irrespective of immune status, TUNEL-positive apoptotic cells were prese

289 arkers that could validate the impaired host immune status under chronic inflammatory conditions, we

290 nical factors, gene expression profiles, and immune status utilizing two published large cohorts.

291 ese findings indicate that assessment of the immune status via Immunoscore provides a potent indicato

292 nges in microbiome structure and function to immune status, virological response and pediatric ART re

293 Offspring immune status was assessed longitudinally by measuring p

294 Tumor immune status was assessed using an immune cell score (I

295 However, the development of this protective immune status was found to be critically dependent on th

296 ulence vary depending on the underlying host immune status, we hypothesized that GT and bmGT producti

297 th, protein catabolism, quality of life, and immune status were assessed at baseline, and changes in

298 Measures of immune status were completed at baseline, 1 month from t

299 Comparisons of immune status were made between the randomised treatment

300 of radiation response were impacted by host immune status, with immunodeficient mice showing early a